Global Liver Failure Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Liver Failure Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Liver Failure Therapeutics industry chain, the market status of Clinic (Ornithine Phenylacetate, MTL-CEBPA), Hospital (Ornithine Phenylacetate, MTL-CEBPA), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Liver Failure Therapeutics.
Regionally, the report analyzes the Liver Failure Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Liver Failure Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Liver Failure Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Liver Failure Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Ornithine Phenylacetate, MTL-CEBPA).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Liver Failure Therapeutics market.
Regional Analysis: The report involves examining the Liver Failure Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Liver Failure Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Liver Failure Therapeutics:
Company Analysis: Report covers individual Liver Failure Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Liver Failure Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinic, Hospital).
Technology Analysis: Report covers specific technologies relevant to Liver Failure Therapeutics. It assesses the current state, advancements, and potential future developments in Liver Failure Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Liver Failure Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Liver Failure Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Liver Failure Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Liver Failure Therapeutics, with revenue, gross margin and global market share of Liver Failure Therapeutics from 2019 to 2024.
Chapter 3, the Liver Failure Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Liver Failure Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Liver Failure Therapeutics.
Chapter 13, to describe Liver Failure Therapeutics research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Liver Failure Therapeutics industry chain, the market status of Clinic (Ornithine Phenylacetate, MTL-CEBPA), Hospital (Ornithine Phenylacetate, MTL-CEBPA), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Liver Failure Therapeutics.
Regionally, the report analyzes the Liver Failure Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Liver Failure Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Liver Failure Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Liver Failure Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Ornithine Phenylacetate, MTL-CEBPA).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Liver Failure Therapeutics market.
Regional Analysis: The report involves examining the Liver Failure Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Liver Failure Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Liver Failure Therapeutics:
Company Analysis: Report covers individual Liver Failure Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Liver Failure Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinic, Hospital).
Technology Analysis: Report covers specific technologies relevant to Liver Failure Therapeutics. It assesses the current state, advancements, and potential future developments in Liver Failure Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Liver Failure Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Liver Failure Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Ornithine Phenylacetate
- MTL-CEBPA
- F-573
- BL-1220
- PP-100
- Others
- Clinic
- Hospital
- Others
- Alfact Innovation
- BioLineRx Ltd
- Cell2B Advanced Therapeutics SA
- Conatus Pharmaceuticals Inc
- Immune Pharmaceuticals Inc
- Mina Therapeutics Ltd
- Mylan NV
- Ocera Therapeutics Inc
- PledPharma AB
- Promethera Biosciences SA
- Silence Therapeutics Plc
- Unicyte AG
- Ventria Bioscience
- Vital Therapies Inc
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Liver Failure Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Liver Failure Therapeutics, with revenue, gross margin and global market share of Liver Failure Therapeutics from 2019 to 2024.
Chapter 3, the Liver Failure Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Liver Failure Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Liver Failure Therapeutics.
Chapter 13, to describe Liver Failure Therapeutics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Liver Failure Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Liver Failure Therapeutics by Type
1.3.1 Overview: Global Liver Failure Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Liver Failure Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Ornithine Phenylacetate
1.3.4 MTL-CEBPA
1.3.5 F-573
1.3.6 BL-1220
1.3.7 PP-100
1.3.8 Others
1.4 Global Liver Failure Therapeutics Market by Application
1.4.1 Overview: Global Liver Failure Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinic
1.4.3 Hospital
1.4.4 Others
1.5 Global Liver Failure Therapeutics Market Size & Forecast
1.6 Global Liver Failure Therapeutics Market Size and Forecast by Region
1.6.1 Global Liver Failure Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Liver Failure Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Liver Failure Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Liver Failure Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Liver Failure Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Liver Failure Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Liver Failure Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Alfact Innovation
2.1.1 Alfact Innovation Details
2.1.2 Alfact Innovation Major Business
2.1.3 Alfact Innovation Liver Failure Therapeutics Product and Solutions
2.1.4 Alfact Innovation Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Alfact Innovation Recent Developments and Future Plans
2.2 BioLineRx Ltd
2.2.1 BioLineRx Ltd Details
2.2.2 BioLineRx Ltd Major Business
2.2.3 BioLineRx Ltd Liver Failure Therapeutics Product and Solutions
2.2.4 BioLineRx Ltd Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioLineRx Ltd Recent Developments and Future Plans
2.3 Cell2B Advanced Therapeutics SA
2.3.1 Cell2B Advanced Therapeutics SA Details
2.3.2 Cell2B Advanced Therapeutics SA Major Business
2.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product and Solutions
2.3.4 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Cell2B Advanced Therapeutics SA Recent Developments and Future Plans
2.4 Conatus Pharmaceuticals Inc
2.4.1 Conatus Pharmaceuticals Inc Details
2.4.2 Conatus Pharmaceuticals Inc Major Business
2.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product and Solutions
2.4.4 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Conatus Pharmaceuticals Inc Recent Developments and Future Plans
2.5 Immune Pharmaceuticals Inc
2.5.1 Immune Pharmaceuticals Inc Details
2.5.2 Immune Pharmaceuticals Inc Major Business
2.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Product and Solutions
2.5.4 Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Immune Pharmaceuticals Inc Recent Developments and Future Plans
2.6 Mina Therapeutics Ltd
2.6.1 Mina Therapeutics Ltd Details
2.6.2 Mina Therapeutics Ltd Major Business
2.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Product and Solutions
2.6.4 Mina Therapeutics Ltd Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Mina Therapeutics Ltd Recent Developments and Future Plans
2.7 Mylan NV
2.7.1 Mylan NV Details
2.7.2 Mylan NV Major Business
2.7.3 Mylan NV Liver Failure Therapeutics Product and Solutions
2.7.4 Mylan NV Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Mylan NV Recent Developments and Future Plans
2.8 Ocera Therapeutics Inc
2.8.1 Ocera Therapeutics Inc Details
2.8.2 Ocera Therapeutics Inc Major Business
2.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Product and Solutions
2.8.4 Ocera Therapeutics Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Ocera Therapeutics Inc Recent Developments and Future Plans
2.9 PledPharma AB
2.9.1 PledPharma AB Details
2.9.2 PledPharma AB Major Business
2.9.3 PledPharma AB Liver Failure Therapeutics Product and Solutions
2.9.4 PledPharma AB Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 PledPharma AB Recent Developments and Future Plans
2.10 Promethera Biosciences SA
2.10.1 Promethera Biosciences SA Details
2.10.2 Promethera Biosciences SA Major Business
2.10.3 Promethera Biosciences SA Liver Failure Therapeutics Product and Solutions
2.10.4 Promethera Biosciences SA Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Promethera Biosciences SA Recent Developments and Future Plans
2.11 Silence Therapeutics Plc
2.11.1 Silence Therapeutics Plc Details
2.11.2 Silence Therapeutics Plc Major Business
2.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Product and Solutions
2.11.4 Silence Therapeutics Plc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Silence Therapeutics Plc Recent Developments and Future Plans
2.12 Unicyte AG
2.12.1 Unicyte AG Details
2.12.2 Unicyte AG Major Business
2.12.3 Unicyte AG Liver Failure Therapeutics Product and Solutions
2.12.4 Unicyte AG Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Unicyte AG Recent Developments and Future Plans
2.13 Ventria Bioscience
2.13.1 Ventria Bioscience Details
2.13.2 Ventria Bioscience Major Business
2.13.3 Ventria Bioscience Liver Failure Therapeutics Product and Solutions
2.13.4 Ventria Bioscience Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Ventria Bioscience Recent Developments and Future Plans
2.14 Vital Therapies Inc
2.14.1 Vital Therapies Inc Details
2.14.2 Vital Therapies Inc Major Business
2.14.3 Vital Therapies Inc Liver Failure Therapeutics Product and Solutions
2.14.4 Vital Therapies Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Vital Therapies Inc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Liver Failure Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Liver Failure Therapeutics by Company Revenue
3.2.2 Top 3 Liver Failure Therapeutics Players Market Share in 2023
3.2.3 Top 6 Liver Failure Therapeutics Players Market Share in 2023
3.3 Liver Failure Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Liver Failure Therapeutics Market: Region Footprint
3.3.2 Liver Failure Therapeutics Market: Company Product Type Footprint
3.3.3 Liver Failure Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Liver Failure Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Liver Failure Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Liver Failure Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Liver Failure Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Liver Failure Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Liver Failure Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Liver Failure Therapeutics Market Size by Country
6.3.1 North America Liver Failure Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Liver Failure Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Liver Failure Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Liver Failure Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Liver Failure Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Liver Failure Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Liver Failure Therapeutics Market Size by Country
7.3.1 Europe Liver Failure Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Liver Failure Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Liver Failure Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Liver Failure Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Liver Failure Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Liver Failure Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Liver Failure Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Liver Failure Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Liver Failure Therapeutics Market Size by Region
8.3.1 Asia-Pacific Liver Failure Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Liver Failure Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Liver Failure Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Liver Failure Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Liver Failure Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Liver Failure Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Liver Failure Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Liver Failure Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Liver Failure Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Liver Failure Therapeutics Market Size by Country
9.3.1 South America Liver Failure Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Liver Failure Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Liver Failure Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Liver Failure Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Liver Failure Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Liver Failure Therapeutics Market Size by Country
10.3.1 Middle East & Africa Liver Failure Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Liver Failure Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Liver Failure Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Liver Failure Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Liver Failure Therapeutics Market Drivers
11.2 Liver Failure Therapeutics Market Restraints
11.3 Liver Failure Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Liver Failure Therapeutics Industry Chain
12.2 Liver Failure Therapeutics Upstream Analysis
12.3 Liver Failure Therapeutics Midstream Analysis
12.4 Liver Failure Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Liver Failure Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Liver Failure Therapeutics by Type
1.3.1 Overview: Global Liver Failure Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Liver Failure Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Ornithine Phenylacetate
1.3.4 MTL-CEBPA
1.3.5 F-573
1.3.6 BL-1220
1.3.7 PP-100
1.3.8 Others
1.4 Global Liver Failure Therapeutics Market by Application
1.4.1 Overview: Global Liver Failure Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinic
1.4.3 Hospital
1.4.4 Others
1.5 Global Liver Failure Therapeutics Market Size & Forecast
1.6 Global Liver Failure Therapeutics Market Size and Forecast by Region
1.6.1 Global Liver Failure Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Liver Failure Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Liver Failure Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Liver Failure Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Liver Failure Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Liver Failure Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Liver Failure Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Alfact Innovation
2.1.1 Alfact Innovation Details
2.1.2 Alfact Innovation Major Business
2.1.3 Alfact Innovation Liver Failure Therapeutics Product and Solutions
2.1.4 Alfact Innovation Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Alfact Innovation Recent Developments and Future Plans
2.2 BioLineRx Ltd
2.2.1 BioLineRx Ltd Details
2.2.2 BioLineRx Ltd Major Business
2.2.3 BioLineRx Ltd Liver Failure Therapeutics Product and Solutions
2.2.4 BioLineRx Ltd Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioLineRx Ltd Recent Developments and Future Plans
2.3 Cell2B Advanced Therapeutics SA
2.3.1 Cell2B Advanced Therapeutics SA Details
2.3.2 Cell2B Advanced Therapeutics SA Major Business
2.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product and Solutions
2.3.4 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Cell2B Advanced Therapeutics SA Recent Developments and Future Plans
2.4 Conatus Pharmaceuticals Inc
2.4.1 Conatus Pharmaceuticals Inc Details
2.4.2 Conatus Pharmaceuticals Inc Major Business
2.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product and Solutions
2.4.4 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Conatus Pharmaceuticals Inc Recent Developments and Future Plans
2.5 Immune Pharmaceuticals Inc
2.5.1 Immune Pharmaceuticals Inc Details
2.5.2 Immune Pharmaceuticals Inc Major Business
2.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Product and Solutions
2.5.4 Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Immune Pharmaceuticals Inc Recent Developments and Future Plans
2.6 Mina Therapeutics Ltd
2.6.1 Mina Therapeutics Ltd Details
2.6.2 Mina Therapeutics Ltd Major Business
2.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Product and Solutions
2.6.4 Mina Therapeutics Ltd Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Mina Therapeutics Ltd Recent Developments and Future Plans
2.7 Mylan NV
2.7.1 Mylan NV Details
2.7.2 Mylan NV Major Business
2.7.3 Mylan NV Liver Failure Therapeutics Product and Solutions
2.7.4 Mylan NV Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Mylan NV Recent Developments and Future Plans
2.8 Ocera Therapeutics Inc
2.8.1 Ocera Therapeutics Inc Details
2.8.2 Ocera Therapeutics Inc Major Business
2.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Product and Solutions
2.8.4 Ocera Therapeutics Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Ocera Therapeutics Inc Recent Developments and Future Plans
2.9 PledPharma AB
2.9.1 PledPharma AB Details
2.9.2 PledPharma AB Major Business
2.9.3 PledPharma AB Liver Failure Therapeutics Product and Solutions
2.9.4 PledPharma AB Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 PledPharma AB Recent Developments and Future Plans
2.10 Promethera Biosciences SA
2.10.1 Promethera Biosciences SA Details
2.10.2 Promethera Biosciences SA Major Business
2.10.3 Promethera Biosciences SA Liver Failure Therapeutics Product and Solutions
2.10.4 Promethera Biosciences SA Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Promethera Biosciences SA Recent Developments and Future Plans
2.11 Silence Therapeutics Plc
2.11.1 Silence Therapeutics Plc Details
2.11.2 Silence Therapeutics Plc Major Business
2.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Product and Solutions
2.11.4 Silence Therapeutics Plc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Silence Therapeutics Plc Recent Developments and Future Plans
2.12 Unicyte AG
2.12.1 Unicyte AG Details
2.12.2 Unicyte AG Major Business
2.12.3 Unicyte AG Liver Failure Therapeutics Product and Solutions
2.12.4 Unicyte AG Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Unicyte AG Recent Developments and Future Plans
2.13 Ventria Bioscience
2.13.1 Ventria Bioscience Details
2.13.2 Ventria Bioscience Major Business
2.13.3 Ventria Bioscience Liver Failure Therapeutics Product and Solutions
2.13.4 Ventria Bioscience Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Ventria Bioscience Recent Developments and Future Plans
2.14 Vital Therapies Inc
2.14.1 Vital Therapies Inc Details
2.14.2 Vital Therapies Inc Major Business
2.14.3 Vital Therapies Inc Liver Failure Therapeutics Product and Solutions
2.14.4 Vital Therapies Inc Liver Failure Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Vital Therapies Inc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Liver Failure Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Liver Failure Therapeutics by Company Revenue
3.2.2 Top 3 Liver Failure Therapeutics Players Market Share in 2023
3.2.3 Top 6 Liver Failure Therapeutics Players Market Share in 2023
3.3 Liver Failure Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Liver Failure Therapeutics Market: Region Footprint
3.3.2 Liver Failure Therapeutics Market: Company Product Type Footprint
3.3.3 Liver Failure Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Liver Failure Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Liver Failure Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Liver Failure Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Liver Failure Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Liver Failure Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Liver Failure Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Liver Failure Therapeutics Market Size by Country
6.3.1 North America Liver Failure Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Liver Failure Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Liver Failure Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Liver Failure Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Liver Failure Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Liver Failure Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Liver Failure Therapeutics Market Size by Country
7.3.1 Europe Liver Failure Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Liver Failure Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Liver Failure Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Liver Failure Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Liver Failure Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Liver Failure Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Liver Failure Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Liver Failure Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Liver Failure Therapeutics Market Size by Region
8.3.1 Asia-Pacific Liver Failure Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Liver Failure Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Liver Failure Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Liver Failure Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Liver Failure Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Liver Failure Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Liver Failure Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Liver Failure Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Liver Failure Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Liver Failure Therapeutics Market Size by Country
9.3.1 South America Liver Failure Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Liver Failure Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Liver Failure Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Liver Failure Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Liver Failure Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Liver Failure Therapeutics Market Size by Country
10.3.1 Middle East & Africa Liver Failure Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Liver Failure Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Liver Failure Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Liver Failure Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Liver Failure Therapeutics Market Drivers
11.2 Liver Failure Therapeutics Market Restraints
11.3 Liver Failure Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Liver Failure Therapeutics Industry Chain
12.2 Liver Failure Therapeutics Upstream Analysis
12.3 Liver Failure Therapeutics Midstream Analysis
12.4 Liver Failure Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Liver Failure Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Liver Failure Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Liver Failure Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Liver Failure Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Alfact Innovation Company Information, Head Office, and Major Competitors
Table 6. Alfact Innovation Major Business
Table 7. Alfact Innovation Liver Failure Therapeutics Product and Solutions
Table 8. Alfact Innovation Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Alfact Innovation Recent Developments and Future Plans
Table 10. BioLineRx Ltd Company Information, Head Office, and Major Competitors
Table 11. BioLineRx Ltd Major Business
Table 12. BioLineRx Ltd Liver Failure Therapeutics Product and Solutions
Table 13. BioLineRx Ltd Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. BioLineRx Ltd Recent Developments and Future Plans
Table 15. Cell2B Advanced Therapeutics SA Company Information, Head Office, and Major Competitors
Table 16. Cell2B Advanced Therapeutics SA Major Business
Table 17. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product and Solutions
Table 18. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Cell2B Advanced Therapeutics SA Recent Developments and Future Plans
Table 20. Conatus Pharmaceuticals Inc Company Information, Head Office, and Major Competitors
Table 21. Conatus Pharmaceuticals Inc Major Business
Table 22. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product and Solutions
Table 23. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Conatus Pharmaceuticals Inc Recent Developments and Future Plans
Table 25. Immune Pharmaceuticals Inc Company Information, Head Office, and Major Competitors
Table 26. Immune Pharmaceuticals Inc Major Business
Table 27. Immune Pharmaceuticals Inc Liver Failure Therapeutics Product and Solutions
Table 28. Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Immune Pharmaceuticals Inc Recent Developments and Future Plans
Table 30. Mina Therapeutics Ltd Company Information, Head Office, and Major Competitors
Table 31. Mina Therapeutics Ltd Major Business
Table 32. Mina Therapeutics Ltd Liver Failure Therapeutics Product and Solutions
Table 33. Mina Therapeutics Ltd Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Mina Therapeutics Ltd Recent Developments and Future Plans
Table 35. Mylan NV Company Information, Head Office, and Major Competitors
Table 36. Mylan NV Major Business
Table 37. Mylan NV Liver Failure Therapeutics Product and Solutions
Table 38. Mylan NV Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Mylan NV Recent Developments and Future Plans
Table 40. Ocera Therapeutics Inc Company Information, Head Office, and Major Competitors
Table 41. Ocera Therapeutics Inc Major Business
Table 42. Ocera Therapeutics Inc Liver Failure Therapeutics Product and Solutions
Table 43. Ocera Therapeutics Inc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Ocera Therapeutics Inc Recent Developments and Future Plans
Table 45. PledPharma AB Company Information, Head Office, and Major Competitors
Table 46. PledPharma AB Major Business
Table 47. PledPharma AB Liver Failure Therapeutics Product and Solutions
Table 48. PledPharma AB Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. PledPharma AB Recent Developments and Future Plans
Table 50. Promethera Biosciences SA Company Information, Head Office, and Major Competitors
Table 51. Promethera Biosciences SA Major Business
Table 52. Promethera Biosciences SA Liver Failure Therapeutics Product and Solutions
Table 53. Promethera Biosciences SA Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Promethera Biosciences SA Recent Developments and Future Plans
Table 55. Silence Therapeutics Plc Company Information, Head Office, and Major Competitors
Table 56. Silence Therapeutics Plc Major Business
Table 57. Silence Therapeutics Plc Liver Failure Therapeutics Product and Solutions
Table 58. Silence Therapeutics Plc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Silence Therapeutics Plc Recent Developments and Future Plans
Table 60. Unicyte AG Company Information, Head Office, and Major Competitors
Table 61. Unicyte AG Major Business
Table 62. Unicyte AG Liver Failure Therapeutics Product and Solutions
Table 63. Unicyte AG Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Unicyte AG Recent Developments and Future Plans
Table 65. Ventria Bioscience Company Information, Head Office, and Major Competitors
Table 66. Ventria Bioscience Major Business
Table 67. Ventria Bioscience Liver Failure Therapeutics Product and Solutions
Table 68. Ventria Bioscience Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Ventria Bioscience Recent Developments and Future Plans
Table 70. Vital Therapies Inc Company Information, Head Office, and Major Competitors
Table 71. Vital Therapies Inc Major Business
Table 72. Vital Therapies Inc Liver Failure Therapeutics Product and Solutions
Table 73. Vital Therapies Inc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Vital Therapies Inc Recent Developments and Future Plans
Table 75. Global Liver Failure Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 76. Global Liver Failure Therapeutics Revenue Share by Players (2019-2024)
Table 77. Breakdown of Liver Failure Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Liver Failure Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Liver Failure Therapeutics Players
Table 80. Liver Failure Therapeutics Market: Company Product Type Footprint
Table 81. Liver Failure Therapeutics Market: Company Product Application Footprint
Table 82. Liver Failure Therapeutics New Market Entrants and Barriers to Market Entry
Table 83. Liver Failure Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Liver Failure Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Liver Failure Therapeutics Consumption Value Share by Type (2019-2024)
Table 86. Global Liver Failure Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 87. Global Liver Failure Therapeutics Consumption Value by Application (2019-2024)
Table 88. Global Liver Failure Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 89. North America Liver Failure Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Liver Failure Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Liver Failure Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 92. North America Liver Failure Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 93. North America Liver Failure Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Liver Failure Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Liver Failure Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Liver Failure Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Liver Failure Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 98. Europe Liver Failure Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 99. Europe Liver Failure Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Liver Failure Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Liver Failure Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Liver Failure Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Liver Failure Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 104. Asia-Pacific Liver Failure Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 105. Asia-Pacific Liver Failure Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Liver Failure Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Liver Failure Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Liver Failure Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Liver Failure Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 110. South America Liver Failure Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 111. South America Liver Failure Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Liver Failure Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Liver Failure Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Liver Failure Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Liver Failure Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 116. Middle East & Africa Liver Failure Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 117. Middle East & Africa Liver Failure Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Liver Failure Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Liver Failure Therapeutics Raw Material
Table 120. Key Suppliers of Liver Failure Therapeutics Raw Materials
Table 1. Global Liver Failure Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Liver Failure Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Liver Failure Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Liver Failure Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Alfact Innovation Company Information, Head Office, and Major Competitors
Table 6. Alfact Innovation Major Business
Table 7. Alfact Innovation Liver Failure Therapeutics Product and Solutions
Table 8. Alfact Innovation Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Alfact Innovation Recent Developments and Future Plans
Table 10. BioLineRx Ltd Company Information, Head Office, and Major Competitors
Table 11. BioLineRx Ltd Major Business
Table 12. BioLineRx Ltd Liver Failure Therapeutics Product and Solutions
Table 13. BioLineRx Ltd Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. BioLineRx Ltd Recent Developments and Future Plans
Table 15. Cell2B Advanced Therapeutics SA Company Information, Head Office, and Major Competitors
Table 16. Cell2B Advanced Therapeutics SA Major Business
Table 17. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product and Solutions
Table 18. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Cell2B Advanced Therapeutics SA Recent Developments and Future Plans
Table 20. Conatus Pharmaceuticals Inc Company Information, Head Office, and Major Competitors
Table 21. Conatus Pharmaceuticals Inc Major Business
Table 22. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product and Solutions
Table 23. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Conatus Pharmaceuticals Inc Recent Developments and Future Plans
Table 25. Immune Pharmaceuticals Inc Company Information, Head Office, and Major Competitors
Table 26. Immune Pharmaceuticals Inc Major Business
Table 27. Immune Pharmaceuticals Inc Liver Failure Therapeutics Product and Solutions
Table 28. Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Immune Pharmaceuticals Inc Recent Developments and Future Plans
Table 30. Mina Therapeutics Ltd Company Information, Head Office, and Major Competitors
Table 31. Mina Therapeutics Ltd Major Business
Table 32. Mina Therapeutics Ltd Liver Failure Therapeutics Product and Solutions
Table 33. Mina Therapeutics Ltd Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Mina Therapeutics Ltd Recent Developments and Future Plans
Table 35. Mylan NV Company Information, Head Office, and Major Competitors
Table 36. Mylan NV Major Business
Table 37. Mylan NV Liver Failure Therapeutics Product and Solutions
Table 38. Mylan NV Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Mylan NV Recent Developments and Future Plans
Table 40. Ocera Therapeutics Inc Company Information, Head Office, and Major Competitors
Table 41. Ocera Therapeutics Inc Major Business
Table 42. Ocera Therapeutics Inc Liver Failure Therapeutics Product and Solutions
Table 43. Ocera Therapeutics Inc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Ocera Therapeutics Inc Recent Developments and Future Plans
Table 45. PledPharma AB Company Information, Head Office, and Major Competitors
Table 46. PledPharma AB Major Business
Table 47. PledPharma AB Liver Failure Therapeutics Product and Solutions
Table 48. PledPharma AB Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. PledPharma AB Recent Developments and Future Plans
Table 50. Promethera Biosciences SA Company Information, Head Office, and Major Competitors
Table 51. Promethera Biosciences SA Major Business
Table 52. Promethera Biosciences SA Liver Failure Therapeutics Product and Solutions
Table 53. Promethera Biosciences SA Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Promethera Biosciences SA Recent Developments and Future Plans
Table 55. Silence Therapeutics Plc Company Information, Head Office, and Major Competitors
Table 56. Silence Therapeutics Plc Major Business
Table 57. Silence Therapeutics Plc Liver Failure Therapeutics Product and Solutions
Table 58. Silence Therapeutics Plc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Silence Therapeutics Plc Recent Developments and Future Plans
Table 60. Unicyte AG Company Information, Head Office, and Major Competitors
Table 61. Unicyte AG Major Business
Table 62. Unicyte AG Liver Failure Therapeutics Product and Solutions
Table 63. Unicyte AG Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Unicyte AG Recent Developments and Future Plans
Table 65. Ventria Bioscience Company Information, Head Office, and Major Competitors
Table 66. Ventria Bioscience Major Business
Table 67. Ventria Bioscience Liver Failure Therapeutics Product and Solutions
Table 68. Ventria Bioscience Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Ventria Bioscience Recent Developments and Future Plans
Table 70. Vital Therapies Inc Company Information, Head Office, and Major Competitors
Table 71. Vital Therapies Inc Major Business
Table 72. Vital Therapies Inc Liver Failure Therapeutics Product and Solutions
Table 73. Vital Therapies Inc Liver Failure Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Vital Therapies Inc Recent Developments and Future Plans
Table 75. Global Liver Failure Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 76. Global Liver Failure Therapeutics Revenue Share by Players (2019-2024)
Table 77. Breakdown of Liver Failure Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Liver Failure Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Liver Failure Therapeutics Players
Table 80. Liver Failure Therapeutics Market: Company Product Type Footprint
Table 81. Liver Failure Therapeutics Market: Company Product Application Footprint
Table 82. Liver Failure Therapeutics New Market Entrants and Barriers to Market Entry
Table 83. Liver Failure Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Liver Failure Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Liver Failure Therapeutics Consumption Value Share by Type (2019-2024)
Table 86. Global Liver Failure Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 87. Global Liver Failure Therapeutics Consumption Value by Application (2019-2024)
Table 88. Global Liver Failure Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 89. North America Liver Failure Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Liver Failure Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Liver Failure Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 92. North America Liver Failure Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 93. North America Liver Failure Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Liver Failure Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Liver Failure Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Liver Failure Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Liver Failure Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 98. Europe Liver Failure Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 99. Europe Liver Failure Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Liver Failure Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Liver Failure Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Liver Failure Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Liver Failure Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 104. Asia-Pacific Liver Failure Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 105. Asia-Pacific Liver Failure Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Liver Failure Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Liver Failure Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Liver Failure Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Liver Failure Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 110. South America Liver Failure Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 111. South America Liver Failure Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Liver Failure Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Liver Failure Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Liver Failure Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Liver Failure Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 116. Middle East & Africa Liver Failure Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 117. Middle East & Africa Liver Failure Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Liver Failure Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Liver Failure Therapeutics Raw Material
Table 120. Key Suppliers of Liver Failure Therapeutics Raw Materials
LIST OF FIGURES
Figure 1. Liver Failure Therapeutics Picture
Figure 2. Global Liver Failure Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Liver Failure Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Ornithine Phenylacetate
Figure 5. MTL-CEBPA
Figure 6. F-573
Figure 7. BL-1220
Figure 8. PP-100
Figure 9. Others
Figure 10. Global Liver Failure Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 11. Liver Failure Therapeutics Consumption Value Market Share by Application in 2023
Figure 12. Clinic Picture
Figure 13. Hospital Picture
Figure 14. Others Picture
Figure 15. Global Liver Failure Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Liver Failure Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Market Liver Failure Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 18. Global Liver Failure Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 19. Global Liver Failure Therapeutics Consumption Value Market Share by Region in 2023
Figure 20. North America Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 21. Europe Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 22. Asia-Pacific Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 23. South America Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 24. Middle East and Africa Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 25. Global Liver Failure Therapeutics Revenue Share by Players in 2023
Figure 26. Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 27. Global Top 3 Players Liver Failure Therapeutics Market Share in 2023
Figure 28. Global Top 6 Players Liver Failure Therapeutics Market Share in 2023
Figure 29. Global Liver Failure Therapeutics Consumption Value Share by Type (2019-2024)
Figure 30. Global Liver Failure Therapeutics Market Share Forecast by Type (2025-2030)
Figure 31. Global Liver Failure Therapeutics Consumption Value Share by Application (2019-2024)
Figure 32. Global Liver Failure Therapeutics Market Share Forecast by Application (2025-2030)
Figure 33. North America Liver Failure Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 34. North America Liver Failure Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 35. North America Liver Failure Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Liver Failure Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 40. Europe Liver Failure Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 41. Europe Liver Failure Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 42. Germany Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. France Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 44. United Kingdom Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 45. Russia Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 46. Italy Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 47. Asia-Pacific Liver Failure Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 48. Asia-Pacific Liver Failure Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 49. Asia-Pacific Liver Failure Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 50. China Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. Japan Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. South Korea Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 53. India Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 54. Southeast Asia Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 55. Australia Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 56. South America Liver Failure Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 57. South America Liver Failure Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 58. South America Liver Failure Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 59. Brazil Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 60. Argentina Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 61. Middle East and Africa Liver Failure Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 62. Middle East and Africa Liver Failure Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 63. Middle East and Africa Liver Failure Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 64. Turkey Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 65. Saudi Arabia Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 66. UAE Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 67. Liver Failure Therapeutics Market Drivers
Figure 68. Liver Failure Therapeutics Market Restraints
Figure 69. Liver Failure Therapeutics Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Liver Failure Therapeutics in 2023
Figure 72. Manufacturing Process Analysis of Liver Failure Therapeutics
Figure 73. Liver Failure Therapeutics Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Liver Failure Therapeutics Picture
Figure 2. Global Liver Failure Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Liver Failure Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Ornithine Phenylacetate
Figure 5. MTL-CEBPA
Figure 6. F-573
Figure 7. BL-1220
Figure 8. PP-100
Figure 9. Others
Figure 10. Global Liver Failure Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 11. Liver Failure Therapeutics Consumption Value Market Share by Application in 2023
Figure 12. Clinic Picture
Figure 13. Hospital Picture
Figure 14. Others Picture
Figure 15. Global Liver Failure Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Liver Failure Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Market Liver Failure Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 18. Global Liver Failure Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 19. Global Liver Failure Therapeutics Consumption Value Market Share by Region in 2023
Figure 20. North America Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 21. Europe Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 22. Asia-Pacific Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 23. South America Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 24. Middle East and Africa Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 25. Global Liver Failure Therapeutics Revenue Share by Players in 2023
Figure 26. Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 27. Global Top 3 Players Liver Failure Therapeutics Market Share in 2023
Figure 28. Global Top 6 Players Liver Failure Therapeutics Market Share in 2023
Figure 29. Global Liver Failure Therapeutics Consumption Value Share by Type (2019-2024)
Figure 30. Global Liver Failure Therapeutics Market Share Forecast by Type (2025-2030)
Figure 31. Global Liver Failure Therapeutics Consumption Value Share by Application (2019-2024)
Figure 32. Global Liver Failure Therapeutics Market Share Forecast by Application (2025-2030)
Figure 33. North America Liver Failure Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 34. North America Liver Failure Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 35. North America Liver Failure Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Liver Failure Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 40. Europe Liver Failure Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 41. Europe Liver Failure Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 42. Germany Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. France Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 44. United Kingdom Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 45. Russia Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 46. Italy Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 47. Asia-Pacific Liver Failure Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 48. Asia-Pacific Liver Failure Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 49. Asia-Pacific Liver Failure Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 50. China Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. Japan Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. South Korea Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 53. India Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 54. Southeast Asia Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 55. Australia Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 56. South America Liver Failure Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 57. South America Liver Failure Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 58. South America Liver Failure Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 59. Brazil Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 60. Argentina Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 61. Middle East and Africa Liver Failure Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 62. Middle East and Africa Liver Failure Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 63. Middle East and Africa Liver Failure Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 64. Turkey Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 65. Saudi Arabia Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 66. UAE Liver Failure Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 67. Liver Failure Therapeutics Market Drivers
Figure 68. Liver Failure Therapeutics Market Restraints
Figure 69. Liver Failure Therapeutics Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Liver Failure Therapeutics in 2023
Figure 72. Manufacturing Process Analysis of Liver Failure Therapeutics
Figure 73. Liver Failure Therapeutics Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
